Yurak yetishmovchiligi va qandli diabet: xavfli aloqalar

Автор: Yusupova Shaxnoza Qodirjonovna, Rashidova Dilfuza Abdumajid qizi

Статья в выпуске: 1 (25), 2025 года.

Бесплатный доступ

So‘nggi ma’lumotlar qandli diabet bilan xastalangan bemorlarda yurak yetishmovchiligi, diabetga chalinmaganlarga qaraganda ko‘proq uchrashini ko‘rsatdi.. Ko‘plab mexanizmlar diabetda yurak faoliyatini yomonlashtiradi, hatto koronar arter kasalligi bo‘lmasa ham yurak yetishmovchiligiga olib keladi. Ushbu maqola diabetdagi yurak yetishmovchiligining tarqalishi, prognozi, mexanizmlari va davolash yondashuvlari bo‘yicha asosiy ma’lumotlarni yoritib beradi.

Surunlaki yurak yetishmovchiligi, uglevod almashinuvining buzilishi, qandli diabet

Короткий адрес: https://sciup.org/14131680

IDR: 14131680

Список литературы Yurak yetishmovchiligi va qandli diabet: xavfli aloqalar

Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119.
Aune D, Schlesinger S, Neuenschwander M, et al. Diabetes mellitus, blood glucose and the risk of heart failure: a systematic review and meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 2018;28:1081–1091. doi: 10.1016/j.numecd.2018.07.005.
Kong MG, Jang SY, Jang J, et al. Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study. Cardiovasc Diabetol 2020;19:49.
Rosano GM, Vitale C, Fragasso G. Metabolic therapy for patients with diabetes mellitus and coronary artery disease. Am J Cardiol 2006;98(5A):14J–18J. DOI:10.1016/jamjcard.2006.07.004; PMID: 16931201: Epub ahead of press
Nagoshi T, Yoshimura M, Rosano GM, et al. Optimization of cardiac metabolism in heart failure. Curr Pharm Des 2011;17(35):3846–53. PMID: 21933140; PMCID:PMC3271354
Rosano GM, Fini M, Caminiti G, Barbaro G. Cardiac metabolism in myocardial ischemia. Curr Pharm Des 2008;14:2551–62. PMID: 18991672
Packer M. Dif f erential pathophysiological mechanisms in heart failure with a reduced or preserved ejection fraction in diabetes. JACC Heart Fail 2021;9:535-49.
Konduracka E, Cieslik G, Galicka-Latala D, et al. Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study. Acta Diabetol 2013;50:597-606.
Packer M. Potentiation of insulin signaling contributes to heart failure in type 2 diabetes: a hypothesis supported by both mechanistic studies and clinical trials. JACC Basic Transl Sci 2018;3:415-9.
Packer M. Dif f erential pathophysiological mechanisms in heart failure with a reduced or preserved ejection fraction in diabetes. JACC Heart Fail 2021;9:535-49.
Jang SY, Jang J, Yang DH, et al. Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus. Cardiovasc Diabetol 2021;20:180.
Dargie HJ, Hildebrandt PR, Riegger GA, et al. A randomized, placebo-controlled trial assessing the ef f ects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure. J Am Coll Cardiol 2007;49:1696-704.
Erdmann E, Charbonnel B, Wilcox RG, et al. Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08). Diabetes Care 2007;30:2773-8.
Packer M. Is metformin benef i cial for heart failure in patients with type 2 diabetes? Diabetes Res Clin Pract 2018;136:168-70.
Liang B, Gu N. Sodium-glucose co-transporter-2 inhibitors in the treatment of diabetes with heart failure. Cardiovasc Diabetol 2022;21:84.
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-726.
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2022;79:e263-421.
Anker SD, Butler J, Filippatos G, et al. Empaglif l ozin in heart failure with a preserved ejection fraction. N Engl J Med 2021;385:1451-61.
Laitinen T, Lyyra-Laitinen T, Huopio H, et al. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Ann Noninvasive Electrocardiol 2008;13:97-105.
Gustafsson I, Brendorp B, Seibaek M, et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol. 2004;43:771-777.

Еще

Статья научная